Adapting versatile
polymers to improve
surgical outcomes
and patient recovery

NEUROCAP®

Publications & Abstracts

At the moment, Polyganics is engaged with several European hospitals in an open non-randomized clinical investigation (STOP NEUROMA Trial: Surgical Treatment Of symPtomatic Neuroma). This trial will be conducted to obtain data on the clinical performance of NEUROCAP’s ability to isolate the nerve end, resulting in a reduction of pain experienced from the symptomatic neuroma and prevention of the reoccurrence of a symptomatic neuroma.

(www.clinicaltrials.gov: identifier: NTC02528266)